Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
25.74
-0.25 (-0.96%)
Oct 27, 2025, 3:11 PM EDT - Market open
Privia Health Group Stock Forecast
Stock Price Forecast
The 13 analysts that cover Privia Health Group stock have a consensus rating of "Strong Buy" and an average price target of $29.08, which forecasts a 12.98% increase in the stock price over the next year. The lowest target is $22 and the highest is $36.
Price Target: $29.08 (+12.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 9 | 9 | 9 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | -14.53% | Oct 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +24.32% | Sep 24, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +24.32% | Sep 4, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $29 → $30 | Buy | Maintains | $29 → $30 | +16.55% | Aug 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | +39.86% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
3.42B
from 1.74B
Increased by 96.90%
Revenue Next Year
3.45B
from 3.42B
Increased by 1.02%
EPS This Year
0.17
from 0.11
Increased by 53.99%
EPS Next Year
0.33
from 0.17
Increased by 92.82%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.6B | 4.0B | |||
| Avg | 3.4B | 3.5B | |||
| Low | 3.2B | 2.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 106.5% | 17.9% | |||
| Avg | 96.9% | 1.0% | |||
| Low | 86.9% | -37.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.24 | 0.44 | |
| Avg | 0.17 | 0.33 | |
| Low | 0.10 | 0.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 119.5% | 160.3% | |
| Avg | 54.0% | 92.8% | |
| Low | -10.9% | 38.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.